Gemini Refractive Capsule
Pre-clinical- Indications
- Cataracts
Company intelligence / Profile preview
Omega Ophthalmics
Versailles, Kentucky, United Statesomegaophthalmics.com ↗
- Ownership
- Private
- Employees
- ~1
- Development stage
- Preclinical
01
Overview
Omega Ophthalmics has developed the Gemini Refractive Capsule™, a novel intraocular lens platform designed to dramatically increase the rate of "glasses-free" outcomes after cataract surgery. Animal studies have shown improved lens positioning, and first-in-human trials were scheduled to begin in 2015. The device also serves as a biologically inert platform for potential integration with sensors, drug delivery systems, and AR/VR technologies. The company claims its technology could revolutionize cataract surgery by reducing surgical variables and enabling new in-eye applications. No published clinical trial results are available.
- Therapeutic areas
- OtherOphthalmology
- Modalities
- DevicePlatform
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 asset03
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed; however, there is reported interest from industry players in ophthalmic, pharmaceutical, and high-tech sectors following their public reveal.
Beyond the preview
Go deeper on Omega Ophthalmics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omega Ophthalmics.